Articles by James Calloway
AST SpaceMobile Stock Climbs on $1.3B Backlog, H2 Revenue Hurdle Looms
AST SpaceMobile shares gained 1.3% to $69.63 after Q2 revenue missed consensus, but contracted backlog rose to $1.30B. The company needs $103.7M-$153.7M in H2 revenue to hit its 2026 target.
Cardinal Health Stock Hits Record High on Strong Fiscal 2027 Outlook
Cardinal Health shares surged to a record high after the company issued a fiscal 2027 earnings forecast that exceeded analyst expectations, driven by strong segment performance.
eToro Beats Q2 Forecasts, Buys TradeZero for $231M to Expand US Reach
eToro exceeded Q2 profit estimates and agreed to acquire TradeZero for up to $231 million, accelerating its US expansion amid shifting trading activity.
Sandisk Gets Buy Rating and $1,600 Target Ahead of Investor Day
Argus Research upgrades Sandisk to Buy with a $1,600 target, citing long-term contracts. Investor Day on Thursday will test the margin trade-off.
Ambiq Q2 Revenue Soars 90%, Supply Constraints Loom
Ambiq Micro's Q2 revenue jumped 90% to $33.9M, beating estimates, but supply constraints could limit future growth. Shares rose 6% premarket.
JBS Names New CEO as Q2 Loss Misses Forecasts
JBS posts a surprise $102.1 million Q2 loss and appoints Wesley Batista Filho as CEO, effective January 2027.
Ouster Expands Utah Lidar Network to Nearly 300 BlueCity Sites
Ouster (OUST) expands BlueCity lidar in Utah by 160 intersections, approaching 300 sites. Q2 revenue up 56% to $54.6M, though net loss remains.
Berkshire Hathaway Boosts Buybacks and Equity Purchases Under New CEO
Berkshire Hathaway (BRK.B) repurchased $4.5B in Q2 2026 and invested $23.5B in equities, signaling a shift in capital allocation under CEO Greg Abel. Operating profit rose 16% to $12.98B.
Smithfield Cuts 2026 Profit Guidance Despite Q2 Beat
Smithfield Foods trimmed its 2026 profit forecast by $100 million at the midpoint, even as Q2 results topped analyst expectations amid margin pressure in packaged meats.
Ferguson Stock Climbs on Robust Non-Residential Demand
Ferguson's shares advanced 2.8% after the company raised its 2026 guidance, citing robust non-residential demand. Q2 sales rose 4.6% and adjusted EPS grew 5.3%.
Rocket Lab Slides 7% as Neutron Delay, Margin Concerns Offset Record Revenue
Rocket Lab shares dropped 7% after hours as investors focused on Neutron's delayed timeline and soft margin forecast, despite a record revenue quarter.
